FDA warns of fake version of ADHD drug Adderall

May 30, 2012 in Attention deficit disorders

FDA warns of fake version of ADHD drug adderall

Counterfeit drug lacks active ingredient; real medicine is currently in short supply.

(HealthDay) -- A counterfeit version of the attention-deficit/hyperactivity disorder drug Adderall, sold online, contains the wrong active ingredients, according to the U.S. Food and Drug Administration.

Adderall is also used to treat narcolepsy. The drug, made by Teva Pharmaceutical Industries, is currently in short supply in the United States.

The counterfeit versions of Adderall are ineffective and potentially harmful, the FDA warned Tuesday.

Authentic Adderall contains four : dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and sulfate. Preliminary by the FDA found that the counterfeit version being sold as Adderall 30-milligram (mg) tablets contains tramadol and acetaminophen, ingredients in medicines used to treat .

Genuine Adderall 30-mg tablets are round, orange/peach in color, and have "dp" embossed on one side and "30" on the other side. The tablets are packaged only in a 100-count bottle with the National Drug Code (NDC) 0555-0768-02, the agency said.

In contrast, the counterfeit tablets are round, white and do not have any type of letters or numbers, the FDA said. Fake tablets may also come in blister packages and have spelling mistakes on the packaging, such as:

  • "NDS" instead of "NDC"

  • "Aspartrte" instead of "Aspartate"

  • "Singel" instead of "Single."
Consumers who believe they have the counterfeit version of 30-mg Adderall tablets should not use them and should talk to their health care professional about their treatment options, the FDA said.

Adderall is currently in short supply because Teva is having difficulty obtaining all of the active ingredients used in the drug. Consumers need to be extra cautious when buying medicines online and remember that drugs in short supply are often targets for counterfeiting, the FDA said.

More information: The U.S. Food and Drug Administration offers a consumer safety guide for buying prescription medicines online.

Copyright © 2012 HealthDay. All rights reserved.

not rated yet  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

Alcedine
May 30, 2012

Rank: not rated yet
They entirely missed an opportunity for giggles when they didn't put speed in. What a shame.
IronhorseA
May 30, 2012

Rank: not rated yet
They entirely missed an opportunity for giggles when they didn't put speed in. What a shame.

Actually I'm surprised the manufacturer didn't just use meth.
Royale
May 31, 2012

Rank: not rated yet
The drug isn't meth. They couldn't use that anyway since Vyvanse already has a patent for a drug that turns into meth inside your body. They'd be stepping on patent toes i'm sure if they did that. Also the FDA would rape Teva for that.
Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Early-life traffic-related air pollution exposure linked to hyperactivity

Early-life exposure to traffic-related air pollution was significantly associated with higher hyperactivity scores at age 7, according to new research from the University of Cincinnati (UC) and Cincinnati Children's Hospital ...

Attention deficit disorders created May 21, 2013 | popularity not rated yet | comments 0 | with audio podcast

First long-term study reveals link between childhood ADHD and obesity

A new study conducted by researchers at the Child Study Center at NYU Langone Medical Center found men diagnosed as children with attention-deficit/hyperactivity disorder (ADHD) were twice as likely to be obese in a 33-year ...

Attention deficit disorders created May 20, 2013 | popularity not rated yet | comments 0 | with audio podcast

Expert explores how sunlight may affect ADHD patients

Researchers are interested in exploring how sunlight, sleep and screens (like those on computers and TVs) may affect those with attention-deficit/hyperactivity disorder (ADHD), says Dr. L. Eugene Arnold, a child psychiatrist ...

Attention deficit disorders created May 17, 2013 | popularity 5 / 5 (3) | comments 1

Long-term ADHD treatment increases brain dopamine transporter levels, may affect drug efficacy

Long-term treatment of attention deficit/hyperactivity disorder (ADHD) with certain stimulant medications may alter the density of the dopamine transporter, according to research published May 15 in the open access journal ...

Attention deficit disorders created May 15, 2013 | popularity not rated yet | comments 0

Can breastfeeding protect against ADHD?

Breastfeeding has a positive impact on the physical and mental development of infants. A new study suggests that breastfeeding may protect against the development of attention-deficit/hyperactivity disorder ...

Attention deficit disorders created May 14, 2013 | popularity not rated yet | comments 0


Hormone replacement therapy—clarity at last

The British Menopause Society and Women's Health Concern have today released updated guidelines on Hormone Replacement Therapy (HRT) to provide clarity around the role of HRT, the benefits and the risks. The new guidelines ...

Controlling mood through the motions of mitochondria

(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...

Motion quotient: IQ predicted by ability to filter motion (w/ video)

A brief visual task can predict IQ, according to a new study. This surprisingly simple exercise measures the brain's unconscious ability to filter out visual movement. The study shows that individuals whose ...

Multiple research teams unable to confirm high-profile Alzheimer's study

Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.

Scientists discover molecule triggers sensation of itch

Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...

Researchers find common childhood asthma unconnected to allergens or inflammation

Little is known about why asthma develops, how it constricts the airway or why response to treatments varies between patients. Now, a team of researchers at Weill Cornell Medical College, Columbia University Medical Center ...